fingolimod hydrochloride has been researched along with Anosmia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bryll, A; Drabik, L; Karcz, P; Kolasinska, J; Kolasinska, M; Marona, M; Popiela, T; Skladzien, J; Slowik, A; Szaleniec, J; Wnuk, M; Ziekiewicz, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Anosmia
Article | Year |
---|---|
Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies.
Topics: Anosmia; Dimethyl Fumarate; Fatigue; Fingolimod Hydrochloride; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Recurrence | 2022 |